TARPLIN, DOWNS & YOUNG, LLC

Lobbying for GENENTECH, INC. · Leading biotechnology co. focused on medicines for serious or life threatening conditions

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Medicare/Medicaid

MINI Act, IRA, Medicare & Medicaid payment and coverage issues, CMMI, orphan drugs

Health Issues

IRA, drug pricing and access, transparency, drug pricing in federal programs, PAPHA reauthorization, supply chain

Budget/Appropriations

Federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.